Share on StockTwits

Mednax (NYSE:MD) Insider Karl B. Wagner unloaded 44,596 shares of Mednax stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $58.53, for a total value of $2,610,203.88. Following the transaction, the insider now directly owns 130,195 shares of the company’s stock, valued at approximately $7,620,313. The sale was disclosed in a filing with the SEC, which is available at this link.

A number of research firms have recently commented on MD. Analysts at Dougherty & Co raised their price target on shares of Mednax from $63.00 to $66.00 in a research note on Monday, May 5th. They now have a “buy” rating on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Mednax in a research note on Thursday, April 17th. They now have a $69.00 price target on the stock. Finally, analysts at Deutsche Bank upgraded shares of Mednax from a “hold” rating to a “buy” rating in a research note on Tuesday, April 1st. They now have a $73.00 price target on the stock, up previously from $57.00. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $83.40.

Shares of Mednax (NYSE:MD) traded up 0.48% on Friday, hitting $58.63. 461,874 shares of the company’s stock traded hands. Mednax has a one year low of $43.565 and a one year high of $64.51. The stock’s 50-day moving average is $57.97 and its 200-day moving average is $57.60. The company has a market cap of $5.809 billion and a price-to-earnings ratio of 20.40.

Mednax (NYSE:MD) last announced its earnings results on Thursday, May 1st. The company reported $0.63 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.63. The company had revenue of $566.00 million for the quarter, compared to the consensus estimate of $574.80 million. During the same quarter in the prior year, the company posted $1.10 earnings per share. The company’s quarterly revenue was up 12.7% on a year-over-year basis. Analysts expect that Mednax will post $3.16 EPS for the current fiscal year.

MEDNAX, Inc (NYSE:MD) is a provider of physician services, including newborn, maternal-fetal, pediatric subspecialties and anesthesia care.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.